168 related articles for article (PubMed ID: 8869094)
1. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.
von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; Litvinov SV; van Kamp GJ; Meijer S; Vermorken J; Hilgers J
Eur J Cancer; 1996 Jul; 32A(8):1325-31. PubMed ID: 8869094
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.
Gourevitch MM; von Mensdorff-Pouilly S; Litvinov SV; Kenemans P; van Kamp GJ; Verstraeten AA; Hilgers J
Br J Cancer; 1995 Oct; 72(4):934-8. PubMed ID: 7547243
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
[TBL] [Abstract][Full Text] [Related]
4. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.
von Mensdorff-Pouilly S; Verstraeten AA; Kenemans P; Snijdewint FG; Kok A; Van Kamp GJ; Paul MA; Van Diest PJ; Meijer S; Hilgers J
J Clin Oncol; 2000 Feb; 18(3):574-83. PubMed ID: 10653872
[TBL] [Abstract][Full Text] [Related]
5. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
6. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; van Kamp GJ; Kok A; van Uffelen K; Snijdewint FG; Paul MA; Meijer S; Hilgers J
Tumour Biol; 1998; 19(3):186-95. PubMed ID: 9591045
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
[TBL] [Abstract][Full Text] [Related]
8. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.
Giai M; Roagna R; Ponzone R; Biglia N; Sgro L; Perona M; Sismondi P
Anticancer Res; 1996; 16(2):875-81. PubMed ID: 8687144
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment values of serum CA 15-3 antigen related to prognostic factors in breast cancer patients.
Wojtacki J; Dziewulska-Bokiniec A; Kowalski DM; Zółtowska A; Ciesielski D; Suszko M
Neoplasma; 1996; 43(4):225-9. PubMed ID: 8931745
[TBL] [Abstract][Full Text] [Related]
10. Tissue and serum MUC1 mucin detection in breast cancer patients.
Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of circulating immune complexes in patients with metastatic breast cancer.
Krieger G; Kehl A; Wander HE; Salo AM; Rauschecker HF; Nagel GA
Int J Cancer; 1983 Feb; 31(2):207-11. PubMed ID: 6826249
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli.
Tang Y; Wang L; Zhang P; Wei H; Gao R; Liu X; Yu Y; Wang L
Clin Vaccine Immunol; 2010 Dec; 17(12):1903-8. PubMed ID: 20876819
[TBL] [Abstract][Full Text] [Related]
13. Characterization of monoclonal antibody 436 recognizing the Arg-Pro-Ala-Pro sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells.
Nuti M; Turchi V; Rughetti A; Viacava P; Masci AM; Castagna M; Frati L
Int J Biol Markers; 1992; 7(2):71-9. PubMed ID: 1378874
[TBL] [Abstract][Full Text] [Related]
14. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the immunohistochemical reaction to human milk fat globule antibodies in node-negative and node-positive breast cancer.
Sterns EE; Fletcher WA; Zee B
Breast Cancer Res Treat; 1992; 21(3):193-9. PubMed ID: 1515653
[TBL] [Abstract][Full Text] [Related]
16. Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.
Bon GG; von Mensdorff-Pouilly S; Kenemans P; van Kamp GJ; Verstraeten RA; Hilgers J; Meijer S; Vermorken JB
Clin Chem; 1997 Apr; 43(4):585-93. PubMed ID: 9105258
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients.
Isla Larrain MT; Colussi AG; Demichelis SO; Barbera A; Cretón A; Segal-Eiras A; Croce MV
Int J Biol Markers; 2013 Sep; 28(3):318-25. PubMed ID: 23828406
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
[TBL] [Abstract][Full Text] [Related]
19. Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region.
Petrarca C; Rughetti A; Rahimi H; D'Agostini F; Turchi V; Apollonj Ghetti C; Scambia G; Frati L; Nuti M
Eur J Cancer; 1996 Nov; 32A(12):2155-63. PubMed ID: 9014760
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]